StonvexLoading…
StonvexStonvexStonvexCore line items from MKSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.08B | $3.93B | $2.90B | $1.91B |
Operating Income | $149.00M | $528.00M | $385.00M | $246.00M |
Net Income | $84.00M | $295.00M | $188.00M | $62.00M |
EPS (Diluted) | $1.18 | $4.37 | $2.78 | $1.69 |
Total Assets | $8.73B | $8.80B | $8.78B | $8.83B |
Total Liabilities | $5.92B | $6.08B | $6.18B | $6.27B |
Cash & Equivalents | $463.00M | $418.00M | $413.00M | $498.00M |
Free Cash Flow OCF − CapEx | $28.00M | $497.00M | $405.00M | $259.00M |
Shares Outstanding | 67.30M | 67.20M | 67.20M | 67.20M |